Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.8M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
70.4M
-
Shares change
-
+3.88M
-
Total reported value, excl. options
-
$838M
-
Value change
-
+$42.5M
-
Put/Call ratio
-
0.1
-
Number of buys
-
89
-
Number of sells
-
-80
-
Price
-
$11.91
Significant Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q1 2025
205 filings reported holding ZYME - Zymeworks Inc. - Common Stock as of Q1 2025.
Zymeworks Inc. - Common Stock (ZYME) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.4M shares
of 74.8M outstanding shares and own 94.08% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (17.3M shares), Redmile Group, LLC (4.79M shares), Rubric Capital Management LP (4.34M shares), BVF INC/IL (4.31M shares), BlackRock, Inc. (4.09M shares), MORGAN STANLEY (4.07M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (3.88M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.2M shares), PERCEPTIVE ADVISORS LLC (1.86M shares), and VANGUARD GROUP INC (1.77M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.